Fairfax, VA USA

Our News on Newswise

ASTRO Commends Medicare’s Decision to Cover Annual, Low-Dose CT Screening for High-Risk Lung Cancer Patients Ages 55 to 74

The American Society for Radiation Oncology (ASTRO) praises the November 11, 2014, decision by the Centers for Medicare and Medicaid Services (CMS) to provide coverage for annual lung cancer screening via low-dose CT screening for those at...
14-Nov-2014 2:00 PM EST

ASTRO Praises Medicare and Congress for Protecting Patient Access to Radiation Oncology Care

The American Society for Radiation Oncology (ASTRO) today applauds the Centers for Medicare and Medicaid Services (CMS) for not implementing proposed payment cuts for radiation therapy starting January 1, 2015, as detailed in the final 2015 Medicare...
3-Nov-2014 4:00 PM EST

Post-Operative Radiation Therapy Improves Overall Survival for Patients with Resected Non-Small Cell Lung Cancer

Patients who received post-operative radiation therapy (PORT), radiation therapy after surgery, lived an average of four months longer when compared to the patients who had the same disease site, tumor histology and treatment criteria and who did...
30-Oct-2014 12:00 PM EDT

10 Years of Data Reveals Excellent, Sustained Local Control with Minimal Side Effects for Medically Inoperable, Early Stage Lung Cancer Patients Who Received High-Dose Rate Stereotactic Body Radiotherapy (SBRT)

Analysis of data from an institutional patient registry on stereotactic body radiotherapy (SBRT) indicates excellent long-term, local control, 79 percent of tumors, for medically inoperable, early stage lung cancer patients treated with SBRT from...
30-Oct-2014 12:00 PM EDT

Patients at High-Risk for Lung Cancer Are More Likely to Receive Screening When Primary Care Provider Is Familiar with Guideline Recommendations

Patients at high-risk for developing lung cancer are more likely to receive low-dose computed tomography (LDCT) screening when their primary care provider is familiar with guideline recommendations for LDCT screening for lung cancer, according to...
30-Oct-2014 11:00 AM EDT

Molecular Tumor Markers Could Reveal New Therapeutic Targets for Lung Cancer Treatment

Analysis of 607 small cell lung cancer (SCLC) lung tumors and neuroendocrine tumors (NET) identified common molecular markers among both groups that could reveal new therapeutic targets for patients with similar types of lung cancer, according to...
30-Oct-2014 11:00 AM EDT

Medicare Costs Analysis Indicates Need for Decreasing Use of Biopsies as Diagnosis Tool for Lung Cancer

Biopsies were found to be the most costly tool prescribed in lung cancer diagnosis, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology.
30-Oct-2014 11:00 AM EDT

Lung Cancer Patients with Minimally Invasive Adenocarcinoma Have Comparable 97.7 Percent Five-Year Survival Rate as Patients with Adenocarcinoma in-situ

Lung cancer patients with minimally invasive adenocarcinoma (MIA) have similar, positive five-year disease-free survival (DFS) and overall survival (OS) rates as patients with adenocarcinoma in-situ (AIS), according to research presented today at...
30-Oct-2014 9:45 AM EDT

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.